Legal Representation
Attorney
Richard A. Friedman
USPTO Deadlines
Next Deadline
39 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
December 10, 2025
Extension Available
Until December 10, 2025
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 30, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 30, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 30, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 25, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 25, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 24, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 24, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 10, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 29, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 29, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 9, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 22, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 19, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 19, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 19, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 19, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 19, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 19, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 5, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 5, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Classification
International Classes
005